Item 1.01 | Entry into a Material Definitive Agreement |
On October 31, 2022, Marsh & McLennan Companies, Inc. (the “Company”) closed its previously announced sale of $500 million aggregate principal amount of its 5.750% Senior Notes due 2032 (the “2032 Notes”) and $500 million aggregate principal amount of its 6.250% Senior Notes due 2052 (the “2052 Notes” and, together with the 2032 Notes, the “Notes”).
The Notes were registered under the Company’s effective shelf registration statement on Form S-3 (Registration No. 333-258194) under the Securities Act of 1933, as amended, as filed with the Securities and Exchange Commission on July 27, 2021 and were offered by means of the Company’s prospectus dated July 27, 2021, as supplemented by the prospectus supplement dated October 24, 2022.
The Notes were issued on October 31, 2022 pursuant to the Indenture dated July 15, 2011, by and between the Company and The Bank of New York Mellon, as trustee (the “Trustee”), filed as Exhibit 4.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011, as supplemented by the Fifteenth Supplemental Indenture (the “Supplemental Indenture”), dated as of October 31, 2022, by and between the Company and the Trustee, which is attached hereto as Exhibit 4.1 and is incorporated herein by reference.
The forms of the 2032 Notes and 2052 Notes are attached hereto as Exhibits 4.2 and 4.3, respectively, and are incorporated herein by reference.
The foregoing descriptions of the Supplemental Indenture and the Notes contained herein are summaries and are qualified in their entirety by the Supplemental Indenture and the forms of Notes attached hereto as Exhibits 4.1, 4.2 and 4.3, respectively.
A copy of the opinion of Davis Polk & Wardwell LLP, counsel to the Company, relating to the legality of the Notes is filed as Exhibit 5.1 hereto.
Item 9.01 | Financial Statements and Exhibits |
(d) Exhibits
2